MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting

X H Zhang1, G L Geng2, B Su3

  • 1Department of Physical Therapy, Wuxi Tongren International Rehabilitation Hospital, Wuxi, Jiangsu, China.

Insights

MicroRNA-338-3p (miR-338-3p) inhibits glucocorticoid-induced osteoclast formation. This microRNA targets RANKL, suggesting a role in osteoporosis by regulating osteoclast differentiation and bone resorption.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Osteoporosis is linked to impaired osteoclast precursor (pre-OC) differentiation.
  • MicroRNAs (miRNAs) are critical regulators of pre-OC differentiation and are implicated in osteoporosis research.
  • Glucocorticoids (GCs) influence bone metabolism, and their associated miRNAs are of recent interest.

Purpose of the Study:

  • To investigate the expression and function of glucocorticoid-associated microRNA-338-3p (miR-338-3p) in osteoclast formation.
  • To elucidate the role of miR-338-3p in glucocorticoid-induced osteoclast differentiation and bone resorption.

Main Methods:

  • Analyzing miR-338-3p expression in response to dexamethasone (a GC) in pre-OCs.
  • Using miR-338-3p mimics and inhibitors to assess effects on osteoclast differentiation and bone resorption.
  • Investigating the regulatory relationship between miR-338-3p and RANKL (receptor activator of nuclear factor kappa-B ligand).
  • Confirming RANKL as a direct target of miR-338-3p and assessing rescue experiments.

Main Results:

  • Dexamethasone treatment inhibited miR-338-3p expression and promoted osteoclast differentiation.
  • Overexpression of miR-338-3p attenuated GC-induced osteoclast formation and bone resorption.
  • Inhibition of miR-338-3p reversed these effects.
  • RANKL expression was inversely correlated with miR-338-3p levels and was identified as a direct target.
  • Re-introducing RANKL reversed the inhibitory effects of miR-338-3p.

Conclusions:

  • miR-338-3p plays a significant role in regulating glucocorticoid-induced osteoclast differentiation and function.
  • The mechanism involves miR-338-3p targeting RANKL, thereby modulating osteoclast activity.
  • These findings offer insights into potential therapeutic strategies for osteoporosis related to GC use.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K